By Business & Finance 
Boston Scientific is our FDI of the Month for April 2026. They are a global medical technology company that develops, manufactures, and markets devices for less-invasive medical specialities.
By Héloïse Chaudot
The American med-tech company Boston Scientific (NYSE: BSX) has announced a €75 million investment in its Galway site, including the expansion of its research and development (R&D) capabilities. It is funded by the Irish government through IDA Ireland.
The development will strengthen its role as a global centre for cardiovascular innovation.
The new capabilities will include purpose-built laboratories to enhance the ability of teams in Galway to design, develop and test next-generation medical technologies across a range of cardiovascular therapies.
With over 7,000 employees in Ireland, Boston Scientific has been established in Ireland for over 30 years. Their presence on the island spans across sites in Galway, Cork, and Clonmel. Each year, they produce over 30 million devices for patients worldwide.
Commenting on the announcement, Minister for Education and Youth, Hildegarde Naughton, said, “The decision by Boston Scientific to invest again in Galway shows real confidence in the talent and infrastructure available here. The importance of R&D and innovation to Ireland’s economy cannot be overstated. It is achieved through a strong partnership between industry, Government and IDA Ireland and has acknowledged that Galway is now an internationally recognised MedTech hub.”
Lance Bates, Executive Vice President and President, Interventional Cardiology and Vascular Therapies, Boston Scientific, added, “The local team is delivering complex, highly collaborative work that is advancing meaningful innovation for patients. The strength of the site, the talent in Ireland and the support of the Irish Government and IDA Ireland give us confidence to continue investing in our future growth.”
Read more FDI:
